US Patent Issued to Baxter International, Baxter Healthcare on Sept. 2 for "Micafungin compositions" (Illinois Inventors)

ALEXANDRIA, Va., Sept. 3 -- United States Patent no. 12,403,173, issued on Sept. 2, was assigned to Baxter International Inc. (Deerfield, Ill.) and Baxter Healthcare SA (Glattpark, Switzerland).

"Micafungin compositions" was invented by Sydney J. Cope (Chicago), Christine L. Rebbeck (Lake Barrington, Ill.) and Mark J. Doty (Grayslake, Ill.).

According to the abstract* released by the U.S. Patent & Trademark Office: "An aqueous pharmaceutical composition suitable for parenteral administration and having enhanced storage stability includes between about 0.1 mg/mL and about 40 mg/mL micafungin; (ii) between about 0.1 mM and 400 mM buffering agent; and (iii) between about 0 mg/mL and about 500 mg/mL tonicity adjusting agent, wherein the pH of...